Novel adjuvant dendritic cell therapy with transfection of heat-shock protein 70 messenger RNA for patients with hepatocellular carcinoma: a phase I/II prospective randomized controlled clinical trial
出版年份 2020 全文链接
标题
Novel adjuvant dendritic cell therapy with transfection of heat-shock protein 70 messenger RNA for patients with hepatocellular carcinoma: a phase I/II prospective randomized controlled clinical trial
作者
关键词
-
出版物
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-10-19
DOI
10.1007/s00262-020-02737-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A phase I study of multi-HLA-binding peptides derived from heat shock protein 70/glypican-3 and a novel combination adjuvant of hLAG-3Ig and Poly-ICLC for patients with metastatic gastrointestinal cancers: YNP01 trial
- (2020) Masao Nakajima et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Identification of a Promiscuous Epitope Peptide Derived From HSP70
- (2019) Hiroto Matsui et al. JOURNAL OF IMMUNOTHERAPY
- Clinical Manifestations and Outcomes of Patients with Sarcomatoid Hepatocellular Carcinoma
- (2018) Sih-Han Liao et al. HEPATOLOGY
- Immune checkpoint blockade for the treatment of human hepatocellular carcinoma
- (2018) Naoshi Nishida et al. HEPATOLOGY RESEARCH
- Chemotherapy for hepatocellular carcinoma: current status and future perspectives
- (2017) Masafumi Ikeda et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Myeloid-derived suppressor cells are increased and correlated with type 2 immune responses, malnutrition, inflammation, and poor prognosis in patients with breast cancer
- (2017) Kenji Gonda et al. Oncology Letters
- Adjuvant immunotherapy with autologous dendritic cells for hepatocellular carcinoma, randomized phase II study
- (2017) Jeong-Hoon Lee et al. OncoImmunology
- Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX–Bevacizumab Drug Treatment Regimen
- (2016) Emeric Limagne et al. CANCER RESEARCH
- Sorafenib after resection improves the outcome of BCLC stage C hepatocellular carcinoma
- (2016) Jiang Li et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Adjuvant sorafenib after heptectomy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma patients
- (2016) Feng Xia et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients
- (2016) Yu Sawada et al. OncoImmunology
- Dendritic cells transfected with heat-shock protein 70 messenger RNA for patients with hepatitis C virus-related hepatocellular carcinoma: a phase 1 dose escalation clinical trial
- (2015) Yoshinari Maeda et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
- (2015) Jordi Bruix et al. LANCET ONCOLOGY
- Elevated chronic inflammatory factors and myeloid-derived suppressor cells indicate poor prognosis in advanced melanoma patients
- (2014) Huanhuan Jiang et al. INTERNATIONAL JOURNAL OF CANCER
- Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma
- (2014) Koichi Shimizu et al. Human Vaccines & Immunotherapeutics
- Comparison of resection and ablation for hepatocellular carcinoma: A cohort study based on a Japanese nationwide survey
- (2012) Kiyoshi Hasegawa et al. JOURNAL OF HEPATOLOGY
- Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression
- (2012) Suzanne Ostrand-Rosenberg et al. SEMINARS IN CANCER BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started